Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shinya Okuda is active.

Publication


Featured researches published by Shinya Okuda.


Bioorganic & Medicinal Chemistry Letters | 2008

Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: discovery of FR264205.

Ayako Toda; Hidenori Ohki; Toshio Yamanaka; Kenji Murano; Shinya Okuda; Kohji Kawabata; Kazuo Hatano; Keiji Matsuda; Keiji Misumi; Kenji Itoh; Kenji Satoh; Satoshi Inoue

We describe herein the synthesis and biological evaluation of a series of novel cephalosporins with potent activity against Pseudomonas aeruginosa. Introduction of various amino groups to the 4-position of a 3-amino-2-methylpyrazole cephalosporin 3-side chain resulted in enhanced MIC values against multiple Pseudomonas aeruginosa strains and ultimately led to the discovery of FR264205 (15) with excellent anti-bacterial activity and weak convulsion effect by direct intracerebroventricular injection assay.


Bioorganic & Medicinal Chemistry | 2002

Orally Active Cephalosporins. Part 4: Synthesis, Structure–Activity Relationships and Oral Absorption of Novel 3-(4-Pyrazolylmethylthio)cephalosporins with Various C-7 Side Chains

Hirofumi Yamamoto; Yoshiteru Eikyu; Shinya Okuda; Kohji Kawabata; Hisashi Takasugi; Hirokazu Tanaka; Satoru Matsumoto; Yoshimi Matsumoto; Shuichi Tawara

A series of 3-(4-pyrazolylmethylthio)cephalosporins with various C-7 side chains was designed, synthesized and evaluated for antibacterial activity and oral absorption in rats. Antibacterial activity against Haemophilus influenzae was markedly increased by the C-7 oxime moiety. Deamination at the 2 position of, or introduction of a substituent such as halogen or methyl to, the 5 position of the (Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino) moiety improved oral absorption. Among these compounds, FR192752 having a (Z)-2-(2-amino-5-chlorothiazol-4-yl)-2-hydroxyiminoacetamido moiety, showed potent antibacterial activity against both Gram-positive and Gram-negative bacteria including H.influenzae and penicillin G-resistant Streptococcus pneumoniae (PRSP). Further, it showed higher oral absorption than CFDN and FK041.


Bioorganic & Medicinal Chemistry | 1997

Studies on 3'-quaternary ammonium cephalosporins--III. Synthesis and antibacterial activity of 3'-(3-aminopyrazolium) cephalosporins.

Hidenori Ohki; Kohji Kawabata; Yoshiko Inamoto; Shinya Okuda; Toshiaki Kamimura; Kazuo Sakane

The synthesis and in vitro antibacterial activity of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]cephalos porins bearing N-mono or dialkyl and carbamoyl aminopyrazolium, and five- or six-membered rings fused to the 3-aminopyrazolium methyl groups at the 3-position, are described. Aminopyrazolium methyl cephalosporins (23e, f, i), with fused saturated and unsaturated rings were especially effective against Staphylococcus strains compared to 3-amino-2-methylpyrazolium methyl cephalosporin (1). Among the cephalosporins prepared in this work, 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-(4,5, 6, 7-tetrahydro-1-pyrazolo[1,5-a]pyrimidinio)methyl-3-cephem-4-carbox ylate (23f) showed a good balance of antibacterial activity against both Gram-positive bacteria including Staphylococcus aureus and Gram-negative bacteria including P. aeruginosa. An imidazopyrazolium group at the 3-position in, for example, cephalosporin (23i) was particularly effective for improving antibacterial activity against MRSA.


Archive | 1994

NEW CEPHEM COMPOUNDS

Kohji Kawabata; Hirofumi Yamamoto; Yoshiteru Eikyu; Shinya Okuda; Hisashi Takasugi


Archive | 1994

Novel cephem compounds

Kazuo Sakane; Kohji Kawabata; Shinya Okuda


Bioorganic & Medicinal Chemistry | 2008

Structural requirements for the stability of novel cephalosporins to AmpC β-lactamase based on 3D-structure

Kenji Murano; Toshio Yamanaka; Ayako Toda; Hidenori Ohki; Shinya Okuda; Kohji Kawabata; Kazuo Hatano; Shinobu Takeda; Hisashi Akamatsu; Kenji Itoh; Keiji Misumi; Satoshi Inoue; Tatsuya Takagi


The Journal of Antibiotics | 1993

FK037, a new parenteral cephalosporin with a broad antibacterial spectrum. Synthesis and antibacterial activity

Hidenori Ohki; Kohji Kawabata; Shinya Okuda; Toshiaki Kamimura; Kazuo Sakane


Archive | 2007

Cephem Compounds and Use as Antimicrobial Agents

Toshio Yamanaka; Ayako Toda; Hidenori Ohki; Shinya Okuda; Kohji Kawabata; Kenji Murano; Kazuo Hatano; Shinobu Takeda; Toru Nakai; Masaru Oogaki; Satoshi Inoue; Keiji Misumi; Kenji Itoh


Archive | 1997

NEW CEPHEM COMPOUNDS AND PHARMACEUTICAL USE THEREOF

Yoshiki Yoshida; Shinya Okuda; Hiroshi Sasaki; Keiji Matsuda; Hisashi Takasugi


Archive | 1997

3-pyrazoliomethylcephem compounds as antimicrobial agents

Kohji Kawabata; Shinya Okuda; Kohei Kishi; Yoshiteru Eikyu; Hisashi Takasugi

Collaboration


Dive into the Shinya Okuda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge